United States · FDA National Drug Code directory
SINSIN MULPAS
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 55264-107_4096c7d0-3f62-3567-e063-6294a90abd4a
- Product NDC
- 55264-107
- Form
- LIQUID
- Composition / generic term
- L-menthol, Methyl salicylate, DL-camphor, Chlorpheniramine maleate, Thymol
- Labeler
- Sinsin Pharmaceutical Co., Ltd.
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20190201
- Source listing expiry
- 20261231
Source-listed ingredients
- CAMPHOR (SYNTHETIC) — 4500 mg/120mL
- METHYL SALICYLATE — 6900 mg/120mL
- CHLORPHENIRAMINE MALEATE — 100 mg/120mL
- MENTHOL — 4200 mg/120mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 CONTAINER in 1 BOX (55264-107-02) / 120 mL in 1 CONTAINER (55264-107-01) · 55264-107-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →